Longeveron Inc. Logo

Longeveron Inc.

LGVN

(0.8)
Stock Price

3,95 USD

-218.86% ROA

-215.74% ROE

-1.27x PER

Market Cap.

29.877.688,00 USD

32.95% DER

0% Yield

-3122.99% NPM

Longeveron Inc. Stock Analysis

Longeveron Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Longeveron Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (21%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

3 ROE

Negative ROE (-106.1%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-131.98%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's elevated P/BV ratio (3.56x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Longeveron Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Longeveron Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Longeveron Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Longeveron Inc. Revenue
Year Revenue Growth
2018 2.134.775
2019 5.639.466 62.15%
2020 5.629.531 -0.18%
2021 1.306.000 -331.05%
2022 1.222.000 -6.87%
2023 600.000 -103.67%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Longeveron Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2018 3.875.842
2019 1.791.842 -116.3%
2020 2.674.370 33%
2021 7.092.000 62.29%
2022 9.370.000 24.31%
2023 7.372.000 -27.1%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Longeveron Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 3.117.260
2019 2.774.953 -12.34%
2020 2.731.174 -1.6%
2021 10.734.000 74.56%
2022 8.119.000 -32.21%
2023 12.368.000 34.35%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Longeveron Inc. EBITDA
Year EBITDA Growth
2018 -5.591.022
2019 -2.190.872 -155.2%
2020 -2.928.830 25.2%
2021 -16.427.000 82.17%
2022 -17.437.000 5.79%
2023 -20.644.000 15.53%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Longeveron Inc. Gross Profit
Year Gross Profit Growth
2018 680.649
2019 1.754.076 61.2%
2020 1.826.270 3.95%
2021 590.000 -209.54%
2022 497.000 -18.71%
2023 216.000 -130.09%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Longeveron Inc. Net Profit
Year Net Profit Growth
2018 -6.336.796
2019 -2.995.507 -111.54%
2020 -3.791.220 20.99%
2021 -17.164.000 77.91%
2022 -19.627.000 12.55%
2023 -23.616.000 16.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Longeveron Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 -1 0%
2022 -1 0%
2023 -1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Longeveron Inc. Free Cashflow
Year Free Cashflow Growth
2018 -5.390.056
2019 -2.515.854 -114.24%
2020 -2.625.404 4.17%
2021 -10.946.000 76.01%
2022 -14.825.000 26.17%
2023 -4.671.000 -217.38%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Longeveron Inc. Operating Cashflow
Year Operating Cashflow Growth
2018 -5.178.372
2019 -2.390.806 -116.6%
2020 -2.363.904 -1.14%
2021 -9.636.000 75.47%
2022 -13.969.000 31.02%
2023 -4.556.000 -206.61%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Longeveron Inc. Capital Expenditure
Year Capital Expenditure Growth
2018 211.684
2019 125.048 -69.28%
2020 261.500 52.18%
2021 1.310.000 80.04%
2022 856.000 -53.04%
2023 115.000 -644.35%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Longeveron Inc. Equity
Year Equity Growth
2018 6.814.277
2019 4.445.042 -53.3%
2020 1.957.067 -127.13%
2021 37.453.000 94.77%
2022 20.503.000 -82.67%
2023 6.632.000 -209.15%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Longeveron Inc. Assets
Year Assets Growth
2018 10.521.702
2019 10.584.415 0.59%
2020 9.240.044 -14.55%
2021 42.766.000 78.39%
2022 27.413.000 -56.01%
2023 11.625.000 -135.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Longeveron Inc. Liabilities
Year Liabilities Growth
2018 3.707.425
2019 6.139.373 39.61%
2020 7.282.977 15.7%
2021 5.313.000 -37.08%
2022 6.910.000 23.11%
2023 4.993.000 -38.39%

Longeveron Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.04
Net Income per Share
-0.94
Price to Earning Ratio
-1.27x
Price To Sales Ratio
38.95x
POCF Ratio
-1.46
PFCF Ratio
-1.67
Price to Book Ratio
3.8
EV to Sales
39.24
EV Over EBITDA
-1.51
EV to Operating CashFlow
-1.74
EV to FreeCashFlow
-1.68
Earnings Yield
-0.79
FreeCashFlow Yield
-0.6
Market Cap
0,03 Bil.
Enterprise Value
0,03 Bil.
Graham Number
2.57
Graham NetNet
-0.05

Income Statement Metrics

Net Income per Share
-0.94
Income Quality
0.87
ROE
-1.45
Return On Assets
-1.82
Return On Capital Employed
-2.54
Net Income per EBT
1
EBT Per Ebit
1.06
Ebit per Revenue
-29.66
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
12.98
Research & Developement to Revenue
13.26
Stock Based Compensation to Revenue
2.95
Gross Profit Margin
-0.02
Operating Profit Margin
-29.66
Pretax Profit Margin
-31.33
Net Profit Margin
-31.23

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.82
Free CashFlow per Share
-0.85
Capex to Operating CashFlow
0.03
Capex to Revenue
-0.77
Capex to Depreciation
-0.63
Return on Invested Capital
-1.79
Return on Tangible Assets
-2.19
Days Sales Outstanding
45.68
Days Payables Outstanding
505.99
Days of Inventory on Hand
0
Receivables Turnover
7.99
Payables Turnover
0.72
Inventory Turnover
0
Capex per Share
-0.03

Balance Sheet

Cash per Share
0,19
Book Value per Share
0,31
Tangible Book Value per Share
0.19
Shareholders Equity per Share
0.31
Interest Debt per Share
0.1
Debt to Equity
0.33
Debt to Assets
0.19
Net Debt to EBITDA
-0.01
Current Ratio
1.49
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.33
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.22
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Longeveron Inc. Dividends
Year Dividends Growth

Longeveron Inc. Profile

About Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

CEO
Mr. Mohamed Wa'el Ahmed Hashad
Employee
23
Address
1951 NW 7th Avenue
Miami, 33136

Longeveron Inc. Executives & BODs

Longeveron Inc. Executives & BODs
# Name Age
1 Ms. Elly Ryu
Vice President & Corporate Controller
70
2 Mr. Paul T. Lehr J.D.
International Executive Director, General Counsel & Secretary
70
3 Dr. Nataliya Agafanova M.D.
Chief Medical Officer
70
4 Dr. Dan Gincel Ph.D.
Senior Vice President of Strategic Collaborations & Scientific Affairs
70
5 Mr. Mohamed Wa'el Ahmed Hashad
Chief Executive Officer & Director
70

Longeveron Inc. Competitors